| Health / Medical Topics |
yttrium Y 90 DOTA monoclonal antibody HuPAM4
Pronunciation
A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90 DOTA monoclonal antibody HuPAM4 contains a monoclonal antibody that binds to a protein called MUC-1, which is found on some pancreatic cancer cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90 DOTA monoclonal antibody HuPAM4 is a type of radioimmunoconjugate. Also called yttrium Y 90 clivatuzumab tetraxetan. (NCI Dictionary)
YOU MAY ALSO LIKE
A substance being studied in the treatment of liver cancer. HuAFP31 is a monoclonal antibody that can bind to tumor cells that…
A substance being studied in the treatment of some types of cancer. M5A is a monoclonal antibody that binds to a protein…
A synthetic radioimmunoconjugate comprised of a humanized anti-interleukin-2 (IL-2) antibody linked to the radioisotope Yttrium 90 with potential antineoplastic activity. Daclizumab…
A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90 clivatuzumab tetraxetan contains a monoclonal antibody that binds…
A radioimmunoconjugate composed of basiliximab, a chimeric, mouse-human monoclonal antibody directed against the alpha subunit of interleukin-2 receptor (IL-2R alpha, CD25 or…
A radioimmunoconjugate comprised of a chimeric monoclonal antibody against human carcinoembryonic antigen (CEA) conjugated with the radioisotope yttrium 90 (Y-90) via the…
